Helicobacter

A Helicobacter finding on a stool microbiome report covers a group of related bacteria. H. pylori is one member of that group. This result reports bacterial DNA at the genus level, so it does not by itself identify H. pylori or establish an active stomach infection.

The distinction changes what you can conclude. H. pylori has a well-established role in ulcers and stomach cancer. The amount of Helicobacter detected as a group in stool is an exploratory microbiome finding, with no validated target for preventing those diseases.

What the Stool Finding Means

Different Helicobacter species occupy different parts of the digestive tract. H. pylori usually lives in the stomach's mucus layer; other species can inhabit the intestine. DNA can reach stool from organisms farther up the digestive tract, so the finding does not locate an infection.

A genus-level result also does not establish whether a strain carries cancer-associated genes or antibiotic-resistance mutations. Those questions require separate, targeted measurements.

Where the Stomach Cancer Evidence Applies

Chronic H. pylori infection causes inflammation of the stomach lining and can lead to ulcers, stomach cancer, and gastric MALT lymphoma. MALT lymphoma is a cancer of immune cells in the stomach. Most people with H. pylori never develop cancer, and many have no symptoms.

The strongest risk estimates concern H. pylori specifically. A case-cohort analysis within a large Chinese study found about six times the risk of cancer in the main part of the stomach among people with evidence of infection. That study measured antibodies in blood, not Helicobacter genus abundance in stool, so the estimate cannot be applied to this result.

A large Taiwanese trial tested an invitation to H. pylori stool antigen screening. Its main analysis did not show a statistically clear reduction in stomach cancer incidence or mortality. An additional analysis that adjusted for participation and other differences suggested about a fifth lower cancer incidence, without a clear mortality reduction. This was species-specific screening, and it does not validate broad Helicobacter profiling as a cancer screen.

What It Means for the Rest of Your Gut

Human studies have linked confirmed H. pylori infection with differences in stool bacterial communities. In one population study, adults with H. pylori infection had different microbiome patterns from matched controls. These observations do not establish that Helicobacter genus abundance causes symptoms or that changing the group total improves health.

When Results Can Be Misleading

• Species differences: a group-level signal cannot establish which Helicobacter species is responsible or assign that species' disease risks.
• DNA detection: genetic material can remain detectable when organisms are no longer alive, which limits conclusions about active infection.
• Stool consistency: water content and the speed of bowel transit affect microbiome measurements. Research on these effects concerns stool bacterial communities generally, not a validated correction for this marker.
• Relative abundance: a percentage can rise when other bacteria decrease, even without an increase in the number of Helicobacter organisms.
• Collection and analysis: contamination, storage, DNA extraction, and the way bacterial DNA is classified can affect the reported result. Values from different microbiome methods or laboratories are not directly interchangeable.

What a Change Over Time Means

Repeated samples can describe changes in the stool signal, but a falling value has not been shown to mean less ulcer or cancer risk. A low or undetected genus result also cannot establish that a previously confirmed H. pylori infection has cleared.